Jinzi Zheng

Dr. Jinzi Zheng plays a pivotal role in the development and commercialization of the Nanovista technology platform. Dr. Zheng is currently a Senior Associate at the CPP Investment Board and was formerly a Consultant at the Boston Consulting Group (BCG) with active involvement in the Healthcare, Biopharma, and Medtech practices. Prior to joining BCG, Dr. Zheng was a Scientist at University Health Network, the largest academic health research institution in Canada, and an Assistant Professor at the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. As a Principal Investigator, Dr. Zheng led numerous collaborations with leading Biopharma and Medtech companies.